Hamilton Lane Advisors LLC Beam Therapeutics Inc. Transaction History

Hamilton Lane Advisors LLC

  • $122 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 14, 2021
SELL
$84.37 - $133.6 $3.98 Million - $6.3 Million
-47,134 Closed
0 $0
Q2 2021

Jul 20, 2021
SELL
$64.12 - $128.71 $3.31 Million - $6.64 Million
-51,627 Reduced 52.27%
47,134 $6.07 Million
Q1 2021

May 05, 2021
BUY
$71.28 - $120.75 $7.04 Million - $11.9 Million
98,761 New
98,761 $7.91 Million

Others Institutions Holding BEAM

# of Institutions
229
Shares Held
70.7M
Call Options Held
283K
Put Options Held
233K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.54B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Hamilton Lane Advisors LLC Portfolio

Follow Hamilton Lane Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Lane Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email